Jodie McVernon

The Royal Melbourne Hospital — Australia

Mathematics · Physical Sciences

42h-index5.9kcitations297works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 epidemiological studies(114), Influenza Virus Research Studies(107), Respiratory viral infections research(41), Bacterial Infections and Vaccines(40), Viral Infections and Outbreaks Research(40)

Publications297 total

The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking
The Journal of Infectious Diseases·2025Open Access
The impact of vaccine products, schedules and geographic regions on immunogenicity of pneumococcal vaccines in children under 2 years old: a systematic review and meta-analysis
2025Open Access
SARS-CoV-2 infection rates and associated risk factors in healthcare settings: systematic review and meta-analysis
2025Open Access
Health impact and cost-effectiveness of COVID-19 booster vaccination strategies in the early post-Omicron era: a dynamic modelling study
BMJ Global Health·2025Open Access
Cost-effectiveness of immunising interventions to reduce respiratory syncytial virus disease burden in infants in Australia
2025Open Access
Enhancing global health security responses through greater inclusion of the global south in infectious disease modelling
BMJ Global Health·2025Open Access
Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2
2025Open Access
Identifying drivers of pertussis disease resurgence pilot study: Final report
2025Open Access
A flexible agent-based modelling framework of multi-serotype pneumococcal carriage to evaluate vaccine strategies in large populations
2025· 1 citedOpen Access
Quantifying the impact of contact tracing interview prioritisation strategies on disease transmission: A modelling study
PLoS Computational Biology·2025Open Access
Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19
Vaccine·2025· 2 citedOpen Access
Epidemiology of Buruli Ulcer in Victoria, Australia, 2017–2022
Emerging infectious diseases·2025· 5 citedOpen Access
SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis
Scientific Reports·2025· 7 citedOpen Access
The Importance of Turnaround and Variant Doubling Times for the Early Detection of Novel and Emerging Viruses using Genomic Surveillance
SSRN Electronic Journal·2025Open Access
Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19
2024Open Access
SARS-CoV-2 infection rates and associated risk factors in healthcare settings: systematic review and meta-analysis
2024Open Access
A model-based assessment of social isolation practices for COVID-19 outbreak response in residential care facilities
BMC Infectious Diseases·2024· 2 citedOpen Access
Differential COVID-19 case ascertainment by age and vaccination status in Victoria, Australia: a serosurveillance and record linkage study
Communicable Diseases Intelligence·2024Open Access
SARS-CoV-2 infection rates and associated risk factors in healthcare settings: systematic review and meta-analysis
2024Open Access
Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19
2024· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

James M. McCaw(22), Mary Ramsay(7), Anne Kelso(7), Ian Barr(6), Karen Laurie(6), Mary Slack(5), Stephen Petrie(5), Teagan Guarnaccia(5), Nicholas Geard(5), Peter Richmond(4), Aeron C. Hurt(4), Louise Carolan(4), Freya M. Shearer(4), Emma S. McBryde(4), James Wood(4), Patricia T. Campbell(4), Terry Nolan(3), Caroline Trotter(3), Ada W. C. Yan(3), Pengxing Cao(3)